Rheumatology Medical News about systemic sclerosis;scleroderma;treatment

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group (EUSTAR)
Annals of Rheumatic Diseases, 02/16/09

Kowal-Bielecka O et al. – Study documents the evidence-based, consensus-derived recommendations useful for rheumatologists to help guide treatment for patients with systemic sclerosis (SSc). These recommendations may also help to define directions for future clinical research in SSc.

Methods

Aim was to develop evidence-based, consensus-derived recommendations for the treatment of SSc
EULAR standard operating procedures were followed
The task force comprised 18 SSc experts from Europe, US, and Japan, 2 SSc pts and 3 fellows for literature research
The preliminary set of research questions concerning SSc treatment was provided by 74 EUSTAR centers

Results

14 recommendations for the treatment of SSc were formulated
The final set included the following recommendations:
3 on SSc-related digital vasculopathy, 4 on SSc-related pulmonary arterial hypertension, 3 on SSc-related gastrointestinal involvement, 2 on scleroderma renal crisis, 1 on SSc-related interstitial lung disease, and 1 on skin involvement
Experts also formulated several questions for a future research agenda

<< Previous
Reference pricing and firms' pricing strategies

Next >>
Intra-articular distribution pattern after ultrasound-guided...